Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

Sun Pharma open to enhance manufacturing footprint in US

Written By Ruchika Sharma6 Nov 2025 5:15 PM IST

New Delhi: Sun Pharma has kept its options open on enhancing its manufacturing footprint in the U.S., even as the U.S. administration's 100%...

Aurobindo Pharma Q3 Net Profit Rises 8% to Rs 910 Cr

Q2 results: Aurobindo Pharma net profit rises 4 percent to Rs 848 crore

Written By Ruchika Sharma6 Nov 2025 3:06 PM IST

New Delhi: Hyderabad-based pharmaceutical giant Aurobindo Pharma Limited has reported a 4 percent jumpin consolidated net profit to Rs 848 crore...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Senores Pharma arm facility gets USFDA EIR

Written By Ruchika Sharma6 Nov 2025 1:55 PM IST

Senores Pharma has announced that the United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma net profit up 3 percent at Rs 3118 crore in Q2

Written By Ruchika Sharma6 Nov 2025 1:00 PM IST

New Delhi: Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India and...

Zydus gets USFDA Orphan Drug Designation for Desidustat for beta-thalassemia

Written By Ruchika Sharma6 Nov 2025 12:00 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the United States Food and Drug Administration (USFDA) has...

Lupin Launches Dasatinib in US Market in Partnership with Pharmascience

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Written By Ruchika Sharma6 Nov 2025 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...

Venus Remedies expands presence in Vietnam with marketing nods for Methotrexate, Cefuroxime, Irinotecan

Written By Ruchika Sharma6 Nov 2025 10:15 AM IST

Venus Remedies Limited has received new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory approvals...

Alembic Pharma net profit up 21 percent at Rs 185 crore in Q2

Written By Ruchika Sharma5 Nov 2025 4:13 PM IST

New Delhi: Alembic Pharmaceuticals Ltd has reported a 21 percent year-on-year rise in consolidated net profit to Rs 185 crore for the quarter ended...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

USFDA issues 9 observations for Canada contract manufacturing facility: Jubilant Pharmova

Written By Ruchika Sharma5 Nov 2025 2:45 PM IST

Noida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded an audit of Jubilant...

Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal

Zydus Wellness net sales up by 31 percent in Q2 FY26

Written By Ruchika Sharma5 Nov 2025 2:15 PM IST

Ahmedabad: Reporting its second quarter results for FY 26, Zydus Wellness Limited, has reported a growth of 31 percent in Net Sales which...

USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XR

USFDA inspection: Granules India Virginia arm gets EIR

Written By Ruchika Sharma5 Nov 2025 1:45 PM IST

Hyderabad: Granules India has announced that the United States Food and Drug Administration (US FDA) has issued an Establishment Inspection...

Zydus gets EIR for SEZ II manufacturing facility in Ahmedabad

Written By Ruchika Sharma5 Nov 2025 12:45 PM IST

Ahmedabad: Zydus has announced that the company has received an Establishment Inspection Report (EIR) from the United States Food and Drugs...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok